Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Iqvia Holdings Inc Stock Research

IQV

205.42USD-3.46(-1.66%)Market Closed
Watchlist

Market Summary

USD205.42-3.46
Market Closed
-1.66%

IQV Stock Price

IQV RSI Chart

IQV Valuation

Market Cap

37.6B

Price/Earnings (Trailing)

34.32

Price/Sales (Trailing)

2.56

EV/EBITDA

11.94

Price/Free Cashflow

16.78

IQV Price/Sales (Trailing)

IQV Profitability

EBT Margin

9.14%

Return on Equity

17.78%

Return on Assets

4.1%

Free Cashflow Yield

5.96%

IQV Fundamentals

IQV Revenue

Revenue (TTM)

14.7B

Revenue Y/Y

5.28%

Revenue Q/Q

2.08%

IQV Earnings

Earnings (TTM)

1.1B

Earnings Y/Y

16.02%

Earnings Q/Q

2.77%

Price Action

52 Week Range

165.75241.86
(Low)(High)

Last 7 days

-3.6%

Last 30 days

-2.4%

Last 90 days

-2.3%

Trailing 12 Months

2.5%

IQV Financial Health

Current Ratio

0.8

IQV Investor Care

Buy Backs (1Y)

2.76%

Diluted EPS (TTM)

5.81

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for IQV

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-03
Bruehlman Ronald E
sold (taxes)
-559,758
216
-2,588
see remarks
2023-07-28
Cherofsky Keriann
sold (taxes)
-7,915
226
-35.00
see remarks
2023-06-05
Knightly Kevin C
sold
-1,175,000
201
-5,820
see remarks
2023-05-26
Knightly Kevin C
sold
-198
198
-1.00
see remarks
2023-05-10
GOGGINS COLLEEN A
acquired
-
-
1,063
-
2023-05-10
Wims Morris Leslie
acquired
-
-
1,063
-
2023-05-10
Burt Carol
acquired
-
-
1,063
-
2023-05-10
Stamps Sheila A
acquired
-
-
1,063
-
2023-05-10
LEONARD JOHN M
acquired
-
-
1,063
-
2023-05-10
Fasano Jim
acquired
-
-
1,063
-

1–10 of 50

Which funds bought or sold IQV recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-12
Farther Finance Advisors, LLC
added
47.5
5,316
13,349
-%
2023-09-07
JAG CAPITAL MANAGEMENT, LLC
new
-
2,447,520
2,447,520
0.28%
2023-09-07
ST GERMAIN D J CO INC
new
-
33,041
33,041
-%
2023-08-29
EFG Asset Management (Americas) Corp.
reduced
-9.82
7,312
389,976
0.09%
2023-08-24
ProVise Management Group, LLC
reduced
-4.1
29,236
378,288
0.03%
2023-08-24
Alberta Investment Management Corp
added
7.39
6,667,960
37,874,200
0.36%
2023-08-23
Stonebridge Capital Advisors LLC
added
0.88
254,214
2,069,680
0.22%
2023-08-22
Old North State Trust, LLC
sold off
-100
-27,000
-
-%
2023-08-22
Asset Dedication, LLC
reduced
-13.51
-1,000
14,000
-%
2023-08-22
COMERICA BANK
new
-
1,000
1,000
-%

1–10 of 48

Latest Funds Activity

Are funds buying IQV calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own IQV
No. of Funds

Schedule 13G FIlings of Iqvia Holdings

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
11.55%
21,447,600
SC 13G/A
Feb 07, 2023
blackrock inc.
8.5%
15,763,249
SC 13G/A
Feb 07, 2022
blackrock inc.
7.9%
15,139,662
SC 13G/A
Feb 10, 2021
vanguard group inc
10.93%
20,954,687
SC 13G/A
Jan 29, 2021
blackrock inc.
7.7%
14,826,277
SC 13G/A
Feb 10, 2020
vanguard group inc
10.03%
19,475,899
SC 13G/A
Feb 10, 2020
vanguard group inc
9.97%
19,346,266
SC 13G/A
Feb 05, 2020
blackrock inc.
7.6%
14,685,767
SC 13G/A
Oct 10, 2019
vanguard group inc
10.24%
20,064,602
SC 13G/A

Recent SEC filings of Iqvia Holdings

View All Filings
Date Filed Form Type Document
Sep 19, 2023
144
Notice of Insider Sale Intent
Aug 07, 2023
4
Insider Trading
Aug 01, 2023
8-K
Current Report
Aug 01, 2023
4
Insider Trading
Aug 01, 2023
10-Q
Quarterly Report

Peers (Alternatives to Iqvia Holdings)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
37.6B
14.7B
-2.38% 2.54%
34.32
2.56
3.86% -5.52%
33.0B
7.0B
-5.82% -14.08%
29.09
4.71
5.03% -14.68%
21.9B
4.5B
-15.96% -29.31%
-5.22
4.9
-4.92% -21931.58%
10.7B
4.2B
4.84% 4.34%
22.1
2.56
13.29% 9.18%
MID-CAP
7.8B
1.7B
2.42% 64.86%
28.97
4.65
30.05% 28.37%
4.4B
5.4B
0.75% -16.37%
62.28
0.82
0.01% -74.39%
2.9B
256.2M
-3.64% -20.61%
-15.97
11.29
2.51% -17.66%
1.6B
551.6M
-5.76% 29.78%
-13.84
2.88
12.73% 21.90%
SMALL-CAP
589.3M
-
-12.75% -21.59%
-11.41
6.7K
- -13.75%
357.7M
22.1M
-18.01% -50.00%
16.15
16.18
43.14% 124.16%
170.9M
66.2M
-71.28% -88.95%
-0.25
2.73
20.37% -7.56%
118.7M
99.2M
5.42% -74.78%
-2.09
1.2
-26.56% -199.52%
64.0M
67.1M
-25.29% -63.99%
-0.58
0.95
-12.13% -17.68%

Iqvia Holdings News

MarketWatch
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors.
MarketWatch,
5 hours ago
InvestorsObserver
Simply Wall St

Returns for IQV

Cumulative Returns on IQV

16.7%


10-Year Cumulative Returns

15.2%


7-Year Cumulative Returns

10.4%


5-Year Cumulative Returns

10.0%


3-Year Cumulative Returns

Risks for IQV

What is the probability of a big loss on IQV?

51.1%


Probability that Iqvia Holdings stock will be more than 20% underwater in next one year

35.4%


Probability that Iqvia Holdings stock will be more than 30% underwater in next one year.

18.5%


Probability that Iqvia Holdings stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does IQV drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Iqvia Holdings was unfortunately bought at previous high price.

Drawdowns

Financials for Iqvia Holdings

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue1.3%14,68114,49414,41014,30714,13614,03313,87413,53612,93112,01411,35910,95610,93911,15811,08810,88110,70610,53310,41210,24510,117
  S&GA Expenses0.0%2,0952,0962,0712,0302,0112,0101,9641,9131,8751,8241,7891,7821,7171,7221,7341,6931,7271,7151,7161,7421,707
EBITDA-100.0%-2,9242,9092,8772,8622,8292,7672,6792,4992,2312,0761,9551,9162,0112,001------
EBITDA Margin-100.0%-0.20*0.20*0.20*0.20*0.20*0.20*0.20*0.19*0.19*0.18*0.18*0.18*0.18*0.18*------
Interest Expenses15.9%546471416378362362375387395409416423437443447444435428414405393
Earnings Before Taxes3.5%1,3721,3251,3631,4641,3771,2711,128946775528373275242345352360342352328257292
EBT Margin-100.0%-0.09*0.09*0.10*0.10*0.09*0.08*0.07*0.06*0.04*0.03*0.03*0.02*0.03*0.03*------
Net Income3.9%1,0961,0551,0911,1821,1601,0799667726124162901871432241912442472482591,2171,245
Net Income Margin-100.0%-0.07*0.08*0.08*0.08*0.08*0.07*0.06*0.05*0.03*0.02*0.02*0.01*0.02*0.02*------
Free Cashflow-100.0%-2,1692,2602,3922,3732,5832,9423,0002,7302,6631,9591,7921,5481,4671,417------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets1.2%26,03625,73925,33724,22324,41324,96924,68924,03323,93724,46724,56423,83723,18323,07823,25122,89223,06823,10922,54922,49822,626
  Current Assets0.0%5,3295,3284,9814,7524,9114,7724,7634,5345,0685,5795,0904,6454,2084,2774,1263,9953,9783,9993,8743,6963,587
    Cash Equivalents-7.5%1,3821,4941,2161,2741,4281,3871,3661,4701,8072,3051,8141,4641,109927837863938936891827879
  Net PPE-1.9%510520532507529531497485470472482452444445458451458437434417415
  Goodwill1.2%14,17814,01513,92113,17713,10413,53213,30113,12412,55112,41512,65412,36312,13311,98912,15911,91911,93711,85711,80011,79411,844
Liabilities2.4%20,28819,80719,57218,87619,06119,05018,64718,20418,17718,23018,28417,73017,33117,27616,98816,49816,28716,24415,59515,03815,012
  Current Liabilities-1.7%6,5436,6575,5785,2535,1045,1575,2414,8474,8194,8684,5584,1393,8433,9073,9453,5763,4953,5023,5343,3803,166
    LT Debt, Current0.1%1,3441,34315215115290.0091.0091.0014714414914414213910098.00100100100101101
    LT Debt, Non Current5.1%12,43311,83312,59512,24312,61512,54712,03412,08112,14012,09212,38412,19511,96511,89411,54511,44411,29911,18710,90710,51810,627
Shareholder's Equity-3.1%5,7485,9325,7655,3475,3525,9196,0425,8295,7606,2376,2806,1075,8525,8026,2636,3946,7816,8656,9547,4607,614
  Retained Earnings8.2%3,9203,6233,3343,1072,8242,5682,2431,9251,6641,4891,2771,1581,0571,080998982925865807726665
Shares Outstanding-1.3%183186186186188190191192192192191191191192192195196197198202206
Minority Interest----------284279261261260260263258250240245250
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations3.4%2,2422,1692,2602,3922,3732,5832,9423,0002,7302,6631,9591,7921,5481,4671,4171,2511,2651,1851,2541,0701,162
  Share Based Compensation2.1%24423919417816516817015413912795.00128122120146122126118113102100
Cashflow From Investing-24.6%-2,012-1,615-2,006-2,176-2,554-2,540-2,103-1,692-788-822-796-840-1,049-1,025-1,190-1,088-870-1,005-810-1,048-1,200
Cashflow From Financing32.1%-262-386-329-274-89.00-923-1,235-1,295-1,282-492-217-362-270-397-276-91.00-331-183-452-24945.00
  Buy Backs0%8948941,1681,3071,1927474063032081644476169141,1499491,2831,1181,4551,4051,1691,594

IQV Income Statement

2023-06-30
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Millions, $ in Millions
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Revenues$ 3,728$ 3,541$ 7,380$ 7,109
Cost of revenues, exclusive of depreciation and amortization2,4432,3314,8414,654
Selling, general and administrative expenses482483995971
Depreciation and amortization259270512525
Restructuring costs2043711
Income from operations524453995948
Interest income(4)(2)(10)(3)
Interest expense16994310180
Other (income) expense, net(16)33(42)43
Income before income taxes and equity in earnings (losses) of unconsolidated affiliates375328737728
Income tax expense8171152142
Income before equity in earnings (losses) of unconsolidated affiliates294257585586
Equity in earnings (losses) of unconsolidated affiliates3(1)1(5)
Net income297256586581
Net Income (Loss) Attributable to Parent, Total$ 297$ 256$ 586$ 581
Earnings per share attributable to common stockholders:    
Basic (in dollars per share)$ 1.61$ 1.36$ 3.17$ 3.07
Diluted (in dollars per share)$ 1.59$ 1.34$ 3.12$ 3.02
Weighted average common shares outstanding:    
Basic (in shares)184.4188.3185.1189.2
Diluted (in shares)186.7191.1187.6192.2

IQV Balance Sheet

2023-06-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 1,382$ 1,216
Trade accounts receivable and unbilled services, net3,1392,917
Prepaid expenses179151
Income taxes receivable4543
Investments in debt, equity and other securities11093
Other current assets and receivables474561
Total current assets5,3294,981
Property and equipment, net510532
Operating lease right-of-use assets319331
Investments in debt, equity and other securities10168
Investments in unconsolidated affiliates10794
Goodwill14,17813,921
Other identifiable intangibles, net4,9424,820
Deferred income taxes115118
Deposits and other assets, net435472
Total assets26,03625,337
Current liabilities:  
Accounts payable and accrued expenses3,0073,316
Unearned income1,8441,797
Income taxes payable208161
Current portion of long-term debt1,344152
Other current liabilities140152
Total current liabilities6,5435,578
Long-term debt, less current portion12,43312,595
Deferred income taxes367464
Operating lease liabilities242264
Other liabilities703671
Total liabilities20,28819,572
Commitments and contingencies (Note 8)
Stockholders’ equity:  
Common stock and additional paid-in capital, 400.0 shares authorized as of June 30, 2023 and December 31, 2022, $0.01 par value, 257.0 shares issued and 183.1 shares outstanding as of June 30, 2023; 256.4 shares issued and 185.7 shares outstanding as of December 31, 202210,95210,898
Retained earnings3,9203,334
Treasury stock, at cost, 73.9 and 70.7 shares as of June 30, 2023 and December 31, 2022, respectively(8,364)(7,740)
Accumulated other comprehensive loss(760)(727)
Total stockholders’ equity5,7485,765
Total liabilities and stockholders’ equity$ 26,036$ 25,337
Ari Bousbib
65535
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.